目錄:MedChemExpress LLC>>信號(hào)通路>> Clopidogrel | 氯吡格雷 | MedChemExpress (MCE)
參考價(jià) | ¥ 550 |
參考價(jià) | ¥ 550 |
更新時(shí)間:2024-01-10 11:27:22瀏覽次數(shù):161評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息,謝謝!
CAS | 113665-84-2 | 純度 | 99.57% |
---|---|---|---|
分子量 | 321.82 | 分子式 | C??H??ClNO?S |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10 mM * 1 mL |
貨號(hào) | HY-15283 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。
CAS No. : 113665-84-2
MCE 國(guó)際站:Clopidogrel
產(chǎn)品活性:Clopidogrel 是一種以 P2Y12 受體為靶點(diǎn)的、具有口服活性的血小板抑制劑。Clopidogrel 可用于抑制冠狀動(dòng)脈疾病、周圍血管疾病和腦血管疾病中的血凝塊。
研究領(lǐng)域:GPCR/G Protein
作用靶點(diǎn):P2Y Receptor
In Vivo: Clopidogrel, administered during the last three months, significantly decreases blood glucose, collagen and fibronectin expression compared to vehicle-treated diabetic mice. Clopidogrel markedly ameliorates hyperglycemia-induced renal fibrosis. The combination therapy of clopidogrel and aspirin (dual-antiplatelet therapy) has been shown to be significantly beneficial compared to aspirin monotherapy and has also shown to decrease sub-acute stent thrombosis as well as recurrent ischemic events following ACS.
相關(guān)產(chǎn)品:Covalent Screening Library Plus | Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Antiviral Compound Library | Drug Repurposing Compound Library | Covalent Screening Library | Anti-diabetic Compound Library | Anti-Cardiovascular Disease Compound Library | NMPA-Approved Drug Library | Orally Active Compound Library | Neurotransmitter Receptor Compound Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Anti-Pancreatic Cancer Compound Library | Targeted Diversity Library | Rare Diseases Drug Library | EMA-Approved Drug Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Non-steroidal Anti-Inflammatory Compound Library | Coagulation and Anti-coagulation Compound Library | Withdrawn Drug Compound Library | Off-patent Drug Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Ticagrelor | Uridine 5′-diphosphoglucose disodium salt | Sodium metatungstate | YM-254890 | MRS 2578 | Uridine-5'-diphosphate disodium salt | Cangrelor tetrasodium | Diquafosol tetrasodium | PPTN hydrochloride | Clopidogrel hydrogen sulfate | BPTU | Prasugrel | PSB-0739 | UDP-Galactose disodium | 2-Methylthio-AMP | P2Y2R/GPR17 antagonist 1 | MRS2500 tetraammonium | N6-(4-Hydroxybenzyl)adenosine | AR-C118925XX | NF157 | Vicagrel | AZD1283 | Elinogrel | PIT | 2-Methylthioadenosine diphosphate trisodium | MRS2179 tetrasodium
熱門(mén)產(chǎn)品線:重組蛋白 | 化合物庫(kù) | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)